AI assistant
Sending…
RESMED INC — Director's Dealing 2023
Nov 20, 2023
30071_dirs_2023-11-20_765df9c8-3d46-47b4-958f-f5481123449a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2023-11-16
Reporting Person: Farrell Michael J. (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-11-20 | ResMed Common Stock | F | 2352.929 | $148.94 | Disposed | 438633 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-11-16 | ResMed Common Stock Options | $148.90 | A | 55468 | Acquired | 2030-11-16 | ResMed Common Stock (55468) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 4090 | Indirect |
Footnotes
F1: Disposition to issuer for tax withholding on vesting of Performance Restricted Stock Units granted on 11/19/2020.
F2: Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2024, 2025, and 2026.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29